1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

12 Feb 2024
Admin
News Article

Isotopia USA Partners with E Solutions to Build Its GMP Manufacturing Center

The facility will encompass 28,000 ft2 of cleanrooms and analytical & microbiological laboratories. Isotopia USA and E Solutions have signed commitments to design-build its GMP manufacturing center.Isotopia plans to establish its US isotope manufacturing operations over the next 12 months and anticipates providing GMP-grade products to its key customers in Q4 2024. The facility will encompass 28,000 ft2 of cleanrooms, analytical and microbiological laboratories needed for high-volume production of Lutetium-177 n.c.a. (177Lu) and Terbium-161(161Tb) isotopes.

These drug substances act as the critical ingredients of targeted nuclear medicine for improving cancer patients' overall survival and quality of life.

Isotopia USA CEO, Todd Hockemeyer stated: "E Solutions and Comfort Systems have a reliable history of executing multiple FDA- regulated installations in the radiopharmaceutical industry on time and within budget. Just as importantly, their expertise in cleanroom technology, clean air ventilation and building management systems make them an important partner in ensuring our success completing this project."

Greg Bielefeld, President of E Solutions, stated: "Our team is very excited to extend our relationship with the world-class professionals at Isotopia. They are an industry leader in the production of cancer treatments, and we cannot be more proud to support them in their endeavor."

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!